Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Inventory: 2022-2024

Historic Inventory for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $5.4 million.

  • Immunocore Holdings' Inventory rose 25.17% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 25.17%. This contributed to the annual value of $5.4 million for FY2024, which is 21.00% up from last year.
  • Per Immunocore Holdings' latest filing, its Inventory stood at $5.4 million for FY2024, which was up 21.00% from $4.5 million recorded in FY2023.
  • Immunocore Holdings' Inventory's 5-year high stood at $5.4 million during FY2024, with a 5-year trough of $692,000 in FY2022.
  • Moreover, its 3-year median value for Inventory was $4.5 million (2023), whereas its average is $3.5 million.
  • Data for Immunocore Holdings' Inventory shows a peak YoY soared of 550.43% (in 2023) over the last 5 years.
  • Immunocore Holdings' Inventory (Yearly) stood at $692,000 in 2022, then skyrocketed by 550.43% to $4.5 million in 2023, then grew by 21.00% to $5.4 million in 2024.